Support FDA Modernization in the US: Take Action Today

Image by Pavel Večerek from Pixabay 

If you live in the U.S., we encourage you to make a call today (Nov. 1, 2022) in support of the FDA Modernization Act, as described in the post below.

Today is the day! It’s National Call-In day for the FDA Modernization Act and we need your help!  It has passed the Senate unanimously and now it must pass the House.

It’s as easy as 1-2-3!

  1. Call the U.S. Capitol switchboard at (202) 224-3121.
  2. An operator will connect you directly to your representative’s office based on your address. You do not need to know the name of your representative.
  3. Once connected to your representative’s office you can read from the following script after identifying your name:

I’m calling to ask my representative to co-sponsor the FDA Modernization Act, H.R. 2565, and also to urge House leaders to bring the FDA Modernization Act 2.0 (S. 5002) to the House floor as soon as possible for a vote. 

The FDA Modernization Act is a landmark bill that would remove FDA’s absolute mandate for animal testing for all new drugs and will give drug developers the option to use cutting-edge, non-animal methods that are superior and humane.

The bill is making waves among scientists, politicians, and health advocates because of its ability to improve delivery of safer, cheaper and more effective drugs for patients while sparing pain and suffering for millions of animals.

The FDA Modernization Act has passed the Senate, but now it must pass the House to become law.

While the bill is doing well with over 100 co-sponsors in both the House and Senate, we can’t take anything for granted! Each year thousands of bills get introduced but only a small portion of those get passed into law.

Please be sure to make this all-important call today to help usher in a new age of drug development without using animals.

From email communication sent by Citizens for Alternatives to Animal Research and Experimentation (CAARE),

Share this item with the buttons below :